Sickle cell related cardiomyopathy and cardiovascular autonomic dysfunction
Sickle cell disease (SCD) is the most common genetic haemoglobinopathy worldwide. Due to advancements in care, SCD patients are living longer. Consequently, there is increased interest in long term sequalae of chronic micro-vascular sickling and resultant end organ damage. Sickle cell cardiomyopathy is an emerging clinical entity characterised by a unique combination of ventricular dilatation, ventricular hypertrophy, diastolic dysfunction and pulmonary hypertension. Additionally, SCD patients have impaired autonomic function which is thought to pre-dispose to vaso-occlusive crises through sympathetic activation and parasympathetic withdrawal during times of physiologic stress. Furthermore, sudden death is a major cause of mortality among patients with SCD, however the mechanism has not been elucidated. This review summarizes the sickle cell cardiomyopathy literature, its relationship with autonomic dysfunction and its association with sudden death.
Authors
- Andrew Maree (ORCID: https://orcid.org/0000-0002-0002-5828)
- James P. Curtain (ORCID: https://orcid.org/0000-0002-1795-7445)
- Emma Tuohy
- Jens Mogensen
- N Connolly
- Ross Murphy
- Rose Anne Kenny
- Sandra Quinn
- Jack Hartnett
Institutions
- Mercer (Czechia) (CZ)
- Trinity College (CA)
- Trinity College Dublin (IE)
- Mayo Clinic in Arizona (US)
- St. James's Hospital (IE)
Publication Details
- Journal
- Frontiers in Cardiovascular Medicine
- Published
- 2026-02-19
- DOI
- https://doi.org/10.3389/fcvm.2026.1756623
- Primary Topic
- Hemoglobinopathies and Related Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00